Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.20    -0.80 (-0.81%)
Bid:
98.20
Ask:
98.80
Spread: 0.60 (0.611%)
Market Cap: £597.25m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

PDMR Dealing

2 Aug 2018 16:49

Syncona Limited - PDMR Dealing

Syncona Limited - PDMR Dealing

PR Newswire

London, August 2

Syncona Limited

Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons

2 August 2018

1.Details of PDMR / person closely associated with them ("PCA")
a)NameMartin Murphy
b)Position / statusChief Executive Officer, SIML
c)Initial notification / amendmentInitial Notification
2.Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrumentOrdinary shares GG00B8P59C08
b)Nature of the transactionAcquisition of shares under the 2018 Dividend
c)Price(s) and volume(s)
Price(s)Volume(s)
2.4182,853
d)Aggregated information Aggregated volume Price N/A
e)Date of the transaction30 July 2018
f)Place of the transactionOutside a trading venue
g)CurrencyGBP – British Pound

EnquiriesCompany SecretaryNorthern Trust International Fund Administration Services (Guernsey) LimitedPO Box 255, Trafalgar CourtLes BanquesSt Peter PortGuernseyGY1 3QL

 +44 (0)1481 745001 

Date   Source Headline
6th Nov 20237:00 amRNSTransaction in Own Shares
2nd Nov 20231:05 pmRNSAutolus to present clinical data updates at ASH
2nd Nov 202311:30 amRNSAutolus reports Q3 2023 Financial Results
2nd Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20233:36 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 202312:00 pmRNSNotice of Results
26th Oct 20237:00 amRNSTransaction in Own Shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
19th Oct 20237:00 amRNSTransaction in Own Shares
18th Oct 202311:00 amRNSProposal to acquire Freeline Therapeutics
18th Oct 20237:00 amRNSTransaction in Own Shares
17th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20237:00 amRNSAnaveon to present clinical data update
16th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
11th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
9th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 202312:05 pmRNSFreeline Announces Positive Initial Clinical Data
4th Oct 202312:05 pmRNSSwanBio Provides Clinical and Financing Update
2nd Oct 20231:20 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:05 amRNSShare Buyback Programme
29th Sep 20237:00 amRNSLaunch of share buyback programme
11th Sep 20237:00 amRNSUpdate on Gyroscope
15th Aug 202312:05 pmRNSFreeline reports Q2 2023 Financial Results
10th Aug 20237:00 amRNSFirst Quarter Update
4th Aug 202312:05 pmRNSPortfolio Update
3rd Aug 202312:05 pmRNSPortfolio Update
1st Aug 20233:08 pmRNSResult of AGM
31st Jul 20231:56 pmRNSTotal Voting Rights
13th Jul 20233:25 pmRNSIssue of shares pursuant to incentive scheme
28th Jun 20237:00 amRNSPublication of 2023 Annual Report & Notice of AGM
15th Jun 20237:00 amRNSFinal Results
12th Jun 20237:00 amRNSSyncona launches new gene therapy company Beacon
9th Jun 20237:00 amRNSQuell signs collaboration with AstraZeneca
7th Jun 20239:34 amRNSChange of Registered Office - Replacement
7th Jun 20237:00 amRNSChange of Registered Office
2nd Jun 202312:05 pmRNSAutolus presents FELIX data at ASCO
30th May 202312:44 pmRNSFreeline reports Q1 2023 Financial Results
19th May 202311:00 amRNSNotice of Results
15th May 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.